Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zeneca Group plc (NYSE ticker ZEN) -- Ignore unavailable to you. Want to Upgrade?

To: Jongmans who wrote (57)	12/8/1998 4:22:00 PM
From: Steven Messina,L.M.T.	Read Replies (1) \| Respond to of 75

I went to the biocognizance.com site and found it to be a tad bit unorganized. I have it bookmarked. The SI ZEN and A threads are comatose. Boi LONG ZEN at 45 1/2

To: Jongmans who wrote (57)	12/8/1998 4:37:00 PM
From: Steven Messina,L.M.T.	Respond to of 75

12/08 16:03 FACT BOX - Zeneca Group and Astra LONDON, Dec 8 (Reuters) - Zeneca Group Plc <ZEN.L> said on Tuesday it was in advanced merger talks with Sweden's Astra<ASTRb.ST> in a deal which would be worth some $68 billion. Following is a table of key data: ZENECA RIC ZEN.L Currency sterling Closing share price Dec 8 2,520p COMPANY SIZE Number of employees 30,000 Market cap (billion stg) 22.976 Shares in issue 949.75 mln FINANCIAL DATA H1 1998 (million sterling) Pretax profit before exceptionals 654 Net profit 428 Turnover 2,895 EPS (pence) 45.1 Total assets 5,337 REVENUE BREAKDOWN (million sterling) Pharmaceuticals 2,565 (49.38 pct) Agrochemicals 1,631 (31.40 pct) Specialities 885 (17.03 pct) Salick Healthcare 121 (2.33 pct) International & Miscellaneous (8) (-0.15 pct) KEY RATIOS PE 31.43 Price/book 10.64 ASTRA Figures for the six months ending June 30, 1998: (million crowns unless stated) Pre-tax earnings 8,253 vs 7,014 Sales 25,157 vs 21,471 EPS (crowns) 3.55 vs 3.07 Sales by product group: Gastrointestinal 13,196 vs 10,132 Cardiovascular 4,405 vs 4,035 Respiratory 4,281 vs 4,008 Pain control 1,820 vs 1,731 Other products 1,072 vs 1,219 Astra Tech 383 vs 346 Total sales 25,157 vs 21,471 Sales by largest products: Losec 13,034 vs 10,015 Pulmicort 2,678 vs 2,480 Seloken 1,614 vs 1,477 Plendil 1,251 vs 1,129 Xylocaine 914 vs 893 Rhinocort 633 vs 638 Total sales by region: North American market 9,520 vs 6,329 Europe 12,500 vs 11,661 Asia, including Japan 1,335 vs 1,678 Total employees as of end-1997 22,206 67 percent of employees work outside Sweden Assets on June 30, 1998 65,338 vs 62,280 NOTE - marketed as Prilosec in the United States. CHRONOLOGY - Mergermania 1998